A review of state-of-the-art therapies currently used with leptomeningeal cancer patients, including information on symptom management, new clinical trials, epidemiology, as well as research in animal models for experimental treatments.
Leptomeningeal Metastases is intended to provide the reader with an overview of the state-of-the-art therapy for the cancer patient with leptomeningeal cancer with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies.Anatomy and Physiology of Leptomeninges and Ventricular system.- Leptomeningeal Neoplasia.- Leptomeningeal Metastases from Leukemias and Lymphomas.- Leptomeningeal Metastases from Solid Tumors.- Leptomeningeal Cancer in the Pediatric Patient.- Leptomeningeal Seeding from Primary CNS Tumors.- Neurosurgical Considerations in Leptomeningeal Cancer.- Current Treatment of Leptomeningeal Cancer.- Animal Models of Leptomeningeal Cancer.- Radiation Therapy for Leptomeningeal Cancer.- Improving the Outcome of Patients with Leptomeningeal Cancer.
Leptomeningeal Metastases provides the reader with an overview of the state-of-the-art therapy for the leptomeningeal patient with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies.
Leptomeningeal metastases remains a devastating manifestation of hematologic malignancies and solid tumors. Leading figures in the field review the pathophysiology and clinical consequences of this process. State-of-the-art treatment strategies are presented highlighting advances in current management.
Steven T. Rosen, M.D.
Series Editor
Provides state-of-the-art therl3Š